Abstract:Idiopathic pulmonary fibrosis (IPF) is an irreversible and fatal lung disease that is primarily found in the elderly population, and several studies have demonstrated that aging is the major risk factor for IPF. IPF is characterized by the presence of apoptosis-resistant, senescent fibroblasts that generate an excessively stiff extracellular matrix (ECM). The ECM profoundly affects cellular functions and tissue homeostasis, and an aberrant ECM is closely associated with the development of lung fibrosis. Aging progressively alters ECM components and is associated with the accumulation of senescent cells that promote age-related tissue dysfunction through the expression of factors linked to a senescence-associated secretary phenotype (SASP). There is growing evidence that SASP factors affect various cell behaviors and influence ECM turnover in lung tissue through autocrine and/or paracrine signaling mechanisms. Since life expectancy is increasing worldwide, it is important to elucidate how aging affects ECM dynamics and turnover via SASP and thereby promotes lung fibrosis. In this review, we will focus on the molecular properties of SASP and its regulatory mechanisms. Furthermore, the pathophysiological process of ECM remodeling by SASP factors and the influence of an altered ECM from aged lungs on the development of lung fibrosis will be highlighted. Finally, recent attempts to target ECM alteration and senescent cells to modulate fibrosis will be introduced.NEW & NOTEWORTHY Aging is the most prominent nonmodifiable risk factor for various human diseases including Idiopathic pulmonary fibrosis. Aging progressively alters extracellular matrix components and is associated with the accumulation of senescent cells that promote age-related tissue dysfunction. In this review, we will discuss the pathological impact of aging and senescence on lung fibrosis via senescence-associated secretary phenotype factors and potential therapeutic approaches to limit the progression of lung fibrosis.

Senescent lung-resident mesenchymal stem cells drive pulmonary fibrogenesis through FGF-4/FOXM1 axis

[Progress on Correlation Between Cell Senescence and Idiopathic Pulmonary Fibrosis].

Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation

Advances in cellular senescence in idiopathic pulmonary fibrosis (Review)

Aged alveolar epithelium contributes to inflammaging and reduced stem cell function in the lung

Molecular Mechanisms of Alveolar Epithelial Stem Cell Senescence and Senescence-Associated Differentiation Disorders in Pulmonary Fibrosis

Senescent AECⅡ and the Implication for Idiopathic Pulmonary Fibrosis Treatment.

A Troy Horse in Pulmonary Fibrosis

Prolonged WNT/ß-catenin signaling induces cellular senescence in aging and pulmonary fibrosis

Cellular Senescence in Lung Fibrosis

Mitochondrial dysfunction contributes to the senescent phenotype of IPF lung fibroblasts

Late Breaking Abstract - Loss of PTEN induces alveolar epithelial cell senescence resulting in lung fibrosis via activated NF-?B

Telomere Dysfunction in Idiopathic Pulmonary Fibrosis

Senescent Fibroblasts Generate a CAF Phenotype through the Stat3 Pathway

The aged extracellular matrix and the profibrotic role of senescence-associated secretory phenotype

Impaired HSF1 transactivation drives proteostasis collapse and senescent phenotype of IPF lung fibroblast

IL-10 deficiency aggravates cell senescence and accelerates BLM-induced pulmonary fibrosis in aged mice via PTEN/AKT/ERK pathway

Regulation of Cellular Senescence Is Independent from Profibrotic Fibroblast-Deposited ECM

Loss of PTEN induces lung fibrosis via alveolar epithelial cell senescence depending on NF‐κB activation

LSC - 2024 - Novel SASP factor mediates fibroblast reprogramming in aging-associated pulmonary fibrosis

Cellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis